AEQUITA PHARMACY: Drug Recall
Recall #D-0559-2025 · 07/18/2025
Class II: Risk
Recall Details
- Recall Number
- D-0559-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- AEQUITA PHARMACY
- Status
- Ongoing
- Date Initiated
- 07/18/2025
- Location
- Kirkland, WA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 143 vials
Reason for Recall
Lack of Processing Controls.
Product Description
Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Distribution Pattern
MA
Other Recalls by AEQUITA PHARMACY
- Class II: Risk 07/18/2025
- Class II: Risk 07/18/2025
- Class II: Risk 07/18/2025
- Class II: Risk 07/18/2025
- Class II: Risk 07/18/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.